Inositol and higher inositol phosphates in neural tissues: Homeostasis, metabolism and functional significance

Journal of Neurochemistry

Volumn 82, Issue 4, 2002, Pages 736-754

  Fisher, Stephen K ^a,b,c   Novak, James E ^a,b   Agranoff, Bernard W ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Affective disorder and treatment; Diphosphoinositol polyphosphates; Inositol hexakisphosphate; Lithium; Na+ myo inositol transporter; Phytate

Indexed keywords

INOSITOL; INOSITOL PHOSPHATE; PHOSPHATIDYLINOSITIDE;

BRAIN METABOLISM; CALCIUM HOMEOSTASIS; CENTRAL NERVOUS SYSTEM; DNA REPAIR; HUMAN; MEMBRANE TRANSPORT; NERVE FUNCTION; NERVOUS TISSUE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA TRANSPORT; SIGNAL TRANSDUCTION; SYNAPTIC MEMBRANE;

ANIMALS; CALCIUM; HOMEOSTASIS; HUMANS; INOSITOL; INOSITOL PHOSPHATES; NERVE TISSUE; NERVOUS SYSTEM DISEASES; ORGAN SPECIFICITY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036677944     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01041.x     Document Type: Review

References (197)

1. Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: Effect of trisomy 16
2. Inositol, lithium and the brain
3. Biological variability in the structures of diphosphoinositol polyphosphates in Dictyostelium discoideum and mammalian cells
4. The interaction of coatomer with inositol polyphosphates is conserved in Saccharomyces cerevisiae
5. Reduced brain inositol in lithium-treated rats
6. Increased brain myo-inositol 1-phosphate in lithiumtreated rats
7. myo-inositol oxygenase, molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol
8. Inositol treatment of Alzheimer's disease: A double blind, crossover placebo controlled trial
9. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder
10. The free myo-inositol concentration of adult and fetal tissues of several species
11. Differential effects of lithium on muscarinic receptor stimulation of inositol phosphates in rat cerebral cortex slices
12. The characteristics, capacity and receptor regulation of inositol uptake in 1321N1 astrocytoma cells
13. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: Depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients
14. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
15. Distribution and properties of CDP-diglyceride: Inositol transferase from brain
16. Inositol trisphosphate and diacylglycerol: Two interacting second messengers
17. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
18. Neural and developmental actions of lithium: A unifying hypothesis
19. +/myoinositol cotransporter gene (SLC5A3): Molecular cloning and localization to chromosome 21
20. In vivo brain myo-inositol levels in children with Down syndrome
21. Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme
22. De l'isomérie optique dans les corps à chaines fermées
23. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells
24. Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog
25. Discovery of molecular and catalytic diversity among human diphosphoinositol-polyphosphate phosphohydrolases. An expanding Nudt family
26. Biochemical studies on inositol. V. Purification and properties of the enzyme that cleaves inositol to D-glucuronic acid
27. The metabolism of myoinositol by the human kidney
28. +/glucose cotransporters
29. Molecular cloning and expression of a rat hepatic multiple inositol polyphosphate phosphatase
30. +) cells
31. The biosynthesis of meso-inositol by cultured mammalian cells, and the parabiotic growth of inositol-dependent and inositol-independent strains
32. Wildiers' bios: The isolation and identification of 'bios I.'
33. Polyphosphoinositides in myelin
34. D-myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis
35. 3H]-inositol into inositol polyphosphates during development of Dictyostelium
36. Overexpression of the inositol phosphatase SopB in human 293 cells stimulates cellular chloride influx and inhibits nuclear mRNA export
37. Receptor activation and inositol lipid hydrolysis in neural tissues
38. Inositol lipids and signal transduction in the nervous system: An update
39. +-selective channels gated by inositol polyphosphates
40. Inositol, a constituent of a brain phosphatide
41. 3H]inositol uptake by dissociated brain cells and cultured fibroblasts from fetal mice
42. 4 BP/synaptotagmin II
43. Inositol treatment of obsessive compulsive disorder
44. A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 α subunit. Implications for the endocytic pathway
45. Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding
46. Purification of phosphatidylinositol synthetase from rat brain by CDP-diacylglycerol affinity chromatography and properties of the purified enzyme
47. Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats
48. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin
49. Turnover of inositol pentakisphosphates, inositol hexakisphosphate and diphosphoinositol polyphosphates in primary cultured hepatocytes
50. Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol
51. Distribution of myo-inositol in the cat cochlear nucleus
52. Taurine, betaine, and inositol share a volume-sensitive transporter in skate erythrocyte cell membrane
53. - channel blockers of the volume-activated, diffusional mechanism of inositol transport in primary astrocytes in culture
54. Phytic acid. A natural antioxidant
55. Effects of phytic acid on renal stone formation in rats
56. Differential effects of lithium on muscarinic cholinoceptor-stimulated CMP-phosphatidate accumulation in cerebellar granule cells, CHO-M3 cells, and SH-SY5Y neuroblastoma cells
57. Inositol prevents folate-resistant neural tube defects in the mouse
58. Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve
59. Control of brain volume during hyperosmolar and hypoosmolar conditions
60. +/myo-inositol cotransporter gene expression
61. +/myo-inositol cotransporter expressed in Xenopus oocytes
62. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain
63. Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair
64. The biosynthesis of free and phosphatide myo-inositol from glucose in mammalian tissues
65. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy
66. Measurement of receptor-activated phosphoinositide turnover in rat brain: Non-equivalence of inositol phosphate and CDP-diacylglycerol formation
67. +/glucose co-transporter
68. Phosphorylation of a synaptic vesicle-associated protein by an inositol hexakisphosphate-regulated protein kinase
69. Properties of a soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase from porcine brain
70. 32 into phospholipides of pancreas slices
71. Effects of acetylcholine on the turnover of phosphoryl units in individual phospholipids of pancreas slices and brain cortex slices
72. Metabolism and function of myo-inositol and inositol phospholipids
73. Molecular cloning of a novel isoform of diphosphoinositol polyphosphate phosphohydrolase: A potential target of lithium therapy
74. Identification and purification of diphosphoinositol pentakisphosphate kinase, which synthesizes the inositol pyrophosphate bis (diphospho) inositol tetrakisphosphate
75. 1H MRS study
76. +-myo-inositol cotransporter in rat brain
77. Independent phosphatidylinositol synthesis in pituitary plasma membrane and endoplasmic reticulum
78. +/MYO-inositol co-transporter mRNA in the rat brain
79. Back in the water: The return of the inositol phosphates
80. Effect of osmolality and myo-inositol deprivation on the transport properties of myo-inositol in primary astrocyte cultures
81. Osmotic regulation of myo-inositol uptake in primary astrocyte cultures
82. Effect of osmolality and anion channel inhibitors on myoinositol efflux in cultured astrocytes
83. Effect of ammonia and methionine sulfoximine on myoinositol transport in cultured astrocytes
84. Effect of dibutyryl cyclic AMP on the kinetics of myo-inositol transport in cultured astrocytes
85. Numbering of atoms in myo-inositol
86. Biochemical and functional characterization of inositol 1,3,4,5,6-pentakisphosphate 2-kinases
87. Identification of the volumesensitive organic osmolyte/anion channel in human glial cells
88. Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux
89. The volume-sensitive organic osmolyte-anion channel VSOAC is regulated by nonhydrolytic ATP binding
90. Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent
91. 1 muscarinic receptors
92. Application of two-dimensional total correlation spectroscopy for structure determination of individual inositol phosphates in a mixture
93. 2+ modulation of myo-inositol transport in cultured retinal pigment epithelial cells
94. Lithium reduces the accumulation of inositol polyphosphate second messengers following cholinergic stimulation of cerebral cortex slices
95. Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices
96. A molecular mechanism for the effect of lithium on development
97. Abundant levels of myo-inositol in cells of human neuronal origin
98. An enzymatic cycling method for the measurement of myo-inositol in biological samples
99. +/myo-inositol cotransporter, a hypertonicity stress protein
100. Functional significance of cell Volume regulatory mechanisms
101. + increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat. The increases require inositol supplementation in mouse and rat but not in guinea pig
102. Brief report: Organic osmolytes in the brain of an infant with hypematremia
103. +-inward rectifying conductance in guard cells
104. Controlled trials of inositol in psychiatry
105. Inositol 6 gm daily may be effective in depression but not in schizophrenia
106. Double blind study of inositol versus placebo in depression
107. Inositol treatment of autism
108. Effects of hypematremia on organic brain osmoles
109. The inositol high-polyphosphate series blocks synaptic transmission by preventing vesicular fusion: A squid giant synapse study
110. Effect of acute and chronic hypematremia on myoinositol and sorbitol concentration in rat brain and kidney
111. Glycosylphosphatidylinositol-anchored proteins and their phospholipases
112. Differential expression, activity and regulation of the sodium/myoinositol cotransporter in astrocyte cultures from different regions of the rat brain
113. An enzymatic fluorimetric assay for myo-inositol
114. Purification, structure, and catalytic properties of 1-myo-inositol-1-phosphate synthase from rat testis
115. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
116. neo-inositol polyphosphates in the amoeba Entamoeba histolytica
117. Effect of extracellular pH on the myo-inositol transporter SMIT expressed in Xenopus oocytes
118. Mass determination of inositol phosphates by high-performance liquid chromatography with postcolumn complexometry (metal-dye detection)
119. Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity
120. Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells
121. Effects of myo-inositol ingestion on human brain myo-inositol levels: A proton magnetic resonance spectroscopic imaging study
122. Changes in brain organic osmolytes in experimental cerebral ischemia
123. +/myo-inositol cotransporter mRNA in rat brain
124. Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol
125. Regulation of myoinositol homeostasis in differentiated human NT2-N neurons
126. Distinct roles of C2A and C2B domains of synaptotagmin in the regulation of exocytosis in adrenal chromaffin cells
127. 3H]chiroinositol in rat tissues
128. Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes
129. +-inositol cotransporter activity and mRNA levels in brain glial cells
130. Differential uptake of myo-inositol in vivo into rat brain areas
131. +-myo-inositol cotransporter gene: Alternate splicing generates diverse transcripts
132. Inositol metabolism during neuroblastoma B50 cell differentiation: Effects of differentiating agents on inositol uptake
133. Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region
134. Hypotonicity-activated efflux of taurine and myo-inositol in rat inner medullary collecting duct cells: Evidence for a major common pathway
135. Role of G-proteins in the regulation of organic osmolyte efflux from isolated rat renal inner medullary collecting duct cells
136. 2-adrenergic receptors through a cAMP-mediated, A-kinaseindependent mechanism
137. A novel context for the 'MutT' module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase
138. Diphosphoinositol polyphosphates: The final frontier for inositide research?
139. The inositol hexakisphosphate kinase family. Catalytic flexibility and function in yeast vacuole biogenesis
140. Mammalian inositol polyphosphate multikinase synthesizes inositol 1,4,5-trisphosphate and an inositol pyrophosphate
141. Identification and characterization of a novel inositol hexakisphosphate kinase
142. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate
143. Ueber eine neue, aus dem Muskelfleische gewonnene Zuckerart
144. Nuclear magnetic resonance spectroscoy of myo-inositol phosphates
145. 13C-NMR
146. Isolation and separation of inositol phosphates from hydrolysates of rat tissues
147. Assessing the omnipotence of inositol hexakisphosphate
148. Synthesis and metabolism of bis-diphosphoinositol tetrakisphosphate in vitro and in vivo
149. The measurement of myo-inositol, myo-inosose-2 and scyllo-inositol in mammalian tissues
150. The identification of myo-inosose-2 and scyllo-inositol in mammalian tissues
151. neo-inositol in mammalian tissues. Identification, measurement, and enzymatic synthesis from mannose 6-phosphate
152. Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring
153. Effects of lithium on phosphoinositide metabolism in vivo
154. Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma
155. Polyol profiles in Down syndrome. myo x Inositol, specifically, is elevated in the cerebrospinal fluid
156. Ts65Dn mouse, a Down syndrome model, exhibits elevated myoinositol in selected brain regions and peripheral tissues
157. Inositol levels are decreased in postmortem brain of schizophrenic patients
158. Role of increased cerebral myo-inositol in the dementia of Down syndrome
159. Kinetic evidence for compartmentalization of myo-inositol in hepatocytes
160. Anaerobic reactions of phospholipins in brain suspensions
161. Protein kinase inhibitors attenuate cardiac swelling-induced amino acid release in the rat
162. The transport and metabolism of scyllo-inositol in the central nervous system
163. The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate (s) and bisdiphosphoinositol tetrakisphosphate (s)
164. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains
165. Free and total lipid myo-inositol concentrations decrease with age in human brain
166. Regulation of solute and water balance and cell Volume in the central nervous system
167. Upregulation of inositol transport mediates inositol accumulation in hyperosmolar brain cells
168. Mechanism and regulation of swelling-activated inositol efflux in brain glial cells
169. +/myo-inositol cotransport in rat cortical astrocytes
170. Lithium enhances muscarinic receptor-stimulated CDP-diacylglycerol formation in inositoldepleted SK-N-SH neuroblastoma cells
171. Inositol hexakisphosphate excites rat medullary sympathoexcitatory neurons in vivo
172. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
173. myo-inositol: A newly identified nonnitrogenous osmoregulatory molecule in mammalian brain
174. Signalling through the lipid products of phosphoinositide-3-OH kinase
175. +)-myoinositol symporter expressed predominantly in the brain
176. Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain
177. Synthesis and function of 3-phosphorylated inositol lipids
178. Cellular injury and cellular death
179. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study
180. Inositol hexakisphosphate receptor identified as the clathrin assembly protein AP-2
181. Purified inositol hexakisphosphate kinase is an ATP synthase: Diphosphoinositol pentakisphosphate as a high-energy phosphate donor
182. Osmotic regulation of Na-myo-inositol cotransporter mRNA level and activity in endothelial and neural cells
183. myo-inositol transport in mouse astroglia-rich primary cultures
184. A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition
185. Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain
186. Myelin proteolipid protein (PLP), but not DM-20, is an inositol hexakisphosphate-binding protein
187. +/myoinositol co-transporter mRNA after rat cryogenic injury
188. 2+ channel activity by stimulation of adenylyl cyclase
189. Inhibition of clathrin assembly by high affinity binding of specific inositol polyphosphates to the synapse-specific clathrin assembly protein
190. Myoinositol uptake by four cultured mammalian cell lines
191. Reduced motor nerve conduction velocity and Na (+)- K (+)-ATPase activity in rats maintained on 1-fucose diet. Reversal by myo-inositol supplementation
192. Abnormal myo-inositol and phospholipid metabolism in cultured fibroblasts from patients with ataxia telangiectasia
193. A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export
194. The determination of inositol in animal tissues